| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 25 |
| 1 | METHYLPREDNISOLONE | 11 |
| 2 | TACROLIMUS | 9 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| 4 | TACROLIMUS OINTMENT 0.1% | 9 |
| 5 | DABIGATRAN ETEXILATE | 8 |
| 6 | DABIGATRAN ETEXILATE MESYLATE | 8 |
| 7 | METOPROLOL | 7 |
| 8 | METOPROLOL TARTRATE | 7 |
| 9 | ALBUTEROL SULFATE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL, UNSPECIFIED | 1 | 0.0100 |
| 1 | FOSNETUPITANT AND PALONOSETRON | 3 | 0.0025 |
| 2 | NETUPITANT AND PALONOSETRON | 3 | 0.0025 |
| 3 | IDARUCIZUMAB | 1 | 0.0007 |
| 4 | FERUMOXYTOL | 1 | 0.0005 |
| 5 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 6 | BELATACEPT | 2 | 0.0004 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 8 | BASILIXIMAB | 4 | 0.0003 |
| 9 | OXYTOCIN | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 3 | Oxytocic [EPC] | 1 | 0.0003 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 4 | 0.0003 |
| 5 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 6 | Factor Xa Inhibitor [EPC] | 27 | 0.0001 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 8 | Androgen [EPC] | 2 | 0.0001 |
| 9 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |